G 0522 G 0522 (Fenofibrate (micronized) 134 mg)
This pill with imprint "G 0522 G 0522" is White, Capsule-shape and has been identified as Fenofibrate (micronized) 134 mg. It is manufactured by Global Pharmaceuticals.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substance Act (CSA).
- G 0522 G 0522
- 134 mg
- 19.00 mm
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Global Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
sodium lauryl sulfate
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|68084-0835||Amerisource Health Services|
|54868-5994||Physicians Total Care Inc (repackager)|
More about fenofibrate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 37 Reviews – Add your own review/rating
- Drug class: fibric acid derivatives
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.